Retrospective study of Macitentan in Patients With Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension
Latest Information Update: 16 Dec 2018
At a glance
- Drugs Macitentan (Primary) ; Riociguat (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
Most Recent Events
- 16 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association